Compare Flux Power Holdings Inc (FLUX) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs ResMed Inc. — how do they compare? Flux Power Holdings Inc trades at $0.47 (market cap $9.97M), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: ResMed Inc. is far larger — about 3198.6× Flux Power Holdings Inc's market cap, and ResMed Inc. pays a 1.16% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 20 Days and ResMed Inc. for 51 Days on average.
| FLUX | RMD | |
|---|---|---|
Market Cap | $9.97M | $31.89B |
Volume | 817,320 | 618,314 |
Sector | Industrials | Health |
52-Week High | $6.66 | $275.96 |
52-Week Low | $0.41 | $182.82 |
Typical Hold Time | 20 Days | 51 Days |
Enterprise Value | $18.18M | $31.24B |
Dividend Yield | — | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.461, down 5.96% today, amid a bearish technical signal and weak earnings. Revenue fell to $42M in 2026 with a net loss of $7M, though the P/S ratio of 0.22 suggests undervaluation. The company rejected an unsolicited acquisition proposal from Solidion Technology in October 2026, adding uncertainty. Analyst consensus remains unanimously bullish with 6 buy ratings, contrasting with negative profitability metrics like a -17.68% net income margin.
The outlook is mixed: strong analyst support and low valuation multiples offer potential upside if execution improves, but persistent losses, declining revenue, and acquisition resistance pose significant risks. Investors should weigh the bullish sentiment against fundamental weaknesses and recent volatility.
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
